全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria

In vitro bioequivalence study of nine brands of artesunate tablets marketed in Nigeria

Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine

An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria

Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial

A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy

Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial

Subacute Therapeutic Dosing of Artemether-Lumefantrine and Artesunate-Amodiaquine Combination Preserves Plasma Cholesterol, Renal Antioxidant Status, and Organ Weights in Rats

Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009

A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan

更多...

Preliminary Study on Counterfeiting of Artemether and Artesunate Marketed in Lubumbashi

DOI: 10.4236/pp.2016.75024, PP. 185-192

Keywords: Counterfeit, Medicines, Antimalarial, Lubumbashi, DR Congo

Full-Text   Cite this paper   Add to My Lib

Abstract:

Pharmaceutical counterfeiting is a health scourge responsible for several cases of morbidity and mortality. Counterfeit medicines cause therapeutic failure, emergence of resistance in the treatment of infections. This study was conducted in order to identify counterfeit and authentic medicines in circulation in Lubumbashi. The study included artemether and artesunate for oral administration. A careful visual inspection of medicine, investigation of authenticity of pharmaceutical products from manufacturers and pharmaceutical regulatory authorities and determination of content were used as study parameters. 52 samples: 37 artemether and 15 of artésunate were collected. 7 samples (13%) have proven to be counterfeit. Artemether was the most counterfeit (71%) and 29% for artesunate. 6 (12%) samples were substandard according to the international pharmacopoeia in terms of content of active ingredient. Sixty-seven percent of non-compliance concerned counterfeit medicines. The proportion of non-compliance is highest among counterfeit medicines (71.43% vs 2.22%; p = 0.000004). It is obvious that strengthening the capacity of the drug regulatory authority of the DRC reduces the influx of counterfeit drug and substandard.

References

[1]  Dégardin, D., Roggo, Y. and Margot, P. (2014) Understanding and Fighting the Medicine Counterfeit Market. Journal of Pharmaceutical and Biomedical Analysis, 87, 167-175.
http://dx.doi.org/10.1016/j.jpba.2013.01.009
[2]  Blackstone, E.A., Fuhr, J.P. and Pociask, S.M.A. (2014) The Health and Economic Effect of Counterfeit Drugs. American Health and Drug Benefits, 7, 216-224.
[3]  Newton, P.N., Tabernero, P. and Dwivedi, P. (2014) Falsified Medicines in Africa: All Talk no Action. Lancet Global Health, 2, e509-e510.
http://dx.doi.org/10.1016/S2214-109X(14)70279-7
[4]  Kelesidis, T. and Falagas, M.E. (2015) Substandard/Counterfeit Antimicrobial Drugs. Clinical Microbiology Reviews, 28, 443-464.
http://dx.doi.org/10.1128/cmr.00072-14
[5]  Fernandez, F.M., Green, M.D. and Newton, P.N. (2008) Prevalence and Detection of Counterfeit Pharmaceuticals: A Mini Review. Industrial and Engineering Chemical, 47, 585-590.
http://dx.doi.org/10.1021/ie0703787
[6]  Mackey, T.K. and Liang, B.A. (2011) The Global Counterfeit Drug Trade: Patient Safety and Public Health Risks. Journal of Pharmaceutical Sciences, 11, 4571-4579.
http://dx.doi.org/10.1002/jps.22679
[7]  Delepierre, A., Gayot, A. and Carpentier, A. (2012) Update on Counterfeiting Antibiotic Worldwide: Public Health Risks. Médecine et Maladies Infectieuses, 42, 247-255.
http://dx.doi.org/10.1016/j.medmal.2012.04.007
[8]  Newton, P., Proux, S., Green, M., Smithuis, F., Rzendaal, J., Prakongpan, S., et al. (2001) Fake Artesunate in Southeast Asia. The Lancet, 357, 1948-1950.
http://dx.doi.org/10.1016/S0140-6736(00)05085-6
[9]  Kelesidis, T., Kelesidis, I., Rafailidis, I.P. and Falagas, M.E. (2007) Counterfeit or Substandard Antimicrobial Drugs: A Review of the Scientific Evidence. Journal of Antimicrobial Chemotherapy, 60, 214-216.
http://dx.doi.org/10.1093/jac/dkm109
[10]  Mbinze, M.J., Nsangu, M.J., Maghe, E., Kobo, S. and Mwanda, R. (2015) Application of Total Error Strategy in Validation of Affordable and Accessible UV-Visible Spectrophotometric Methods for Quality Control of Poor Medicines. American Journal of Analytical Chemistry, 6, 106-117.
http://dx.doi.org/10.4236/ajac.2015.62010
[11]  Liusheng, H., Sunil, P., Rosenthal, P.J., Patricia, L., Marzan, F. and Dorsey, G. (2012) Concomitant Efavirenz Reduces Pharmacokinetic Exposure to the Antimalarial Drug Artemether-Lumefanthrine in Healthy Volunteers. Journal of Acquired Immune Deficiency Syndromes, 61, 310-316.
[12]  Morris, A.C., Duparc, S., Borghini-Fuhrer, I., Jung, D., Shin, C.-S. and Fleckenstein, L. (2011) Review of the Clinical Pharmacokinetic of Artésunate and Its Active Metabolite Dihydroartemisinin Following Intravenous, Intramuscular, Oral or Rectal Administration. Malaria Journal, 10, 263.
http://dx.doi.org/10.1186/1475-2875-10-263
[13]  WHO. Counterfeit Drugs, Guidelines for the Development of Measure to Combat Counterfeit Drugs. Department of Essential Drugs and Other Medicines. Geneva, Switzerland.
http://apps.who.int/iris/bitstream/10665/65892/1/WHO_EDM_QSM_99.1.pdf
[14]  Aka, E., Legris, C., Tanimoto, T., Matsushita, R. and Kimura, K. (2005) Counterfeit Medicine Detection by Authenticity Investigation: A Pilot Study in the Street Market of Côte d’Ivoire. Japanese Society of Social Pharmacy, 24, 7-16.
[15]  Khail, M.H., Hatanaka, K., Sovanarith, T., Nivanna, N., Cadena, L.C. and Yoshida, N. (2013) Effects of Packaging and Storage Conditions on the Quality of Amoxicillin-Clavulanic Acide—An Analysis of Cambodian Samples. Pharmacology and Toxicology, 14, 33-45.
[16]  WHO. International Pharmacopeia. Tests and General Requirements for Dosage Forms Pharmaceutical Substances and Tablets. Vol.5, 3rd Edition, Geneva.
[17]  Nnanga, N., Eboumbou, M., Ngene, J.P., Ewoudou, M.E.R. and Mpondo, M.E. (2015) Pharmaco-Technical Evaluation of Antimalarial Drugs from Licit and Illicit Market in Yaounde Case Of Artemether-Lumefanthrine 20/120. Health Sci. Dis, 16, 1-5.
[18]  Tipke, M., Diallo, S., Coulibaly, B., Störzinger, D., Hoppe-tichy, T., Sie, A. and Müller, O. (2008) Substandard Anti-Malarial Drugs in Burkina Faso. Malaria Journal, 7, 95.
[19]  Bate, R., Coticelli, P., Tren, R. and Attaran, A. (2008) Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa—A Six Country Study. PLoS ONE, 3, e2132.
[20]  Dondorp, A.M., Newton, P.N., Mayxay, M., Van Damme, W., Smithuis, F.M., Yeung, S., et al. (2004) Fake Antimalarials in Southeast Asia Are a Major Impediment to Malaria Control: Multinational Cross-Sectional Survey on the Prevalence of Fake Antimalarials. Tropical Medicine & International Health, 9, 1241-1246.
http://dx.doi.org/10.1111/j.1365-3156.2004.01342.x

Full-Text

comments powered by Disqus